Shock, Septic: all 890 studies

Page 9 of 9. Open to participants first (210), then studies with results posted, then the rest; newest registration first within each.

• ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic ShockCompletedNCT01448109Phase 4
• Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.CompletedNCT01411670Phase 2
• IMproved PREdiction of Severe Sepsis in the Emergency DepartmentCompletedNCT01392508
• SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICUCompletedNCT01378169
• Lactated Ringer Versus Albumin in Early Sepsis TherapyCompletedNCT01337934Phase 3
• Microcirculatory Changes During Magnesium Sulphate Infusion in SepsisCompletedNCT01332734
• The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock PatientsCompletedNCT01319630
• GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic ShockTerminatedNCT01315496Phase 3
• Early Goal-directed Therapy and Myocardial DysfunctionStatus unknownNCT01312688Not applicable
• Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic ShockCompletedNCT01310790Phase 4
• Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic ShockStatus unknownNCT01304680
• Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock PatientsTerminatedNCT01296789Not applicable
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)CompletedNCT01284452Not applicable
• Effects of Dobutamine on Microcirculation, Regional and Peripheral Perfusion in Septic Shock PatientsCompletedNCT01271153Not applicable
• Hypertonic Saline and Terlipressin for Sepsis-associated HypotensionTerminatedNCT01271114Phase 3
• Thermodilution - Controlled Management of Volume Therapy in Septic ShockCompletedNCT01263977Not applicable
• Safety of Heparin in Patients With Septic ShockWithdrawnNCT01234285Phase 2
• Heart Rate Control With Esmolol in Septic ShockCompletedNCT01231698Phase 2
• Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic ShockCompletedNCT01231672
• Simultaneously Using Traditional Chinese Medicine (Si-Ni-Tang) to Treat Septic Shock PatientsTerminatedNCT01223430Phase 2
• Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic ShockCompletedNCT01222663Phase 3
• Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)Status unknownNCT01213914Not applicable
• Transpulmonary Thermodilution and Transesophageal Echocardiography in Early Septic ShockCompletedNCT01188993Phase 4
• Medical Education for Sepsis Source Control and AntibioticsCompletedNCT01187134Not applicable
• Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic ShockCompletedNCT01149278Not applicable
• Transcutaneous Electric Muscle Stimulation (TEMS) in Septic PatientsCompletedNCT01071343Not applicable
• Continuous Hemodialysis With an Enhanced Middle Molecule Clearance MembraneCompletedNCT01067313Phase 2/3
• Pilot Study of Bevacizumab (Avastin) in Patients With Septic ShockWithdrawnNCT01063010Not applicable
• Near Infrared Spectroscopy (St02)CompletedNCT01062685
• Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic ControlCompletedNCT01013662Not applicable
• Terlipressin in Septic Shock: Effects on MicrocirculationCompletedNCT00995839Phase 2/3
• Phase I STEBVax in Healthy AdultsCompletedNCT00974935Phase 1
• Scandinavian Starch for Severe Sepsis/Septic Shock TrialCompletedNCT00962156Phase 3
• Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe InfectionsCompletedNCT00934011Not applicable
• Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer PatientsCompletedNCT00930085Not applicable
• Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic ShockCompletedNCT00922870Not applicable
• Adrenal Insufficiency in Septic ShockTerminatedNCT00842933Phase 4
• Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney InjuryStatus unknownNCT00837057Phase 4
• Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe SepsisCompletedNCT00832039Phase 3
• Rapid Administration of Insulin in SepsisCompletedNCT00823108Phase 1
• Fluid Resuscitation in Early Septic ShockCompletedNCT00819416Phase 2
• Extracorporeal Immune Support System (EISS) for the Treatment of Septic PatientsCompletedNCT00818597Phase 1/2
• Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic ShockTerminatedNCT00816790Phase 4
• Glycosaminoglycans During Septic Shock - a Temporal StudyWithdrawnNCT00814112
• Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU PatientsCompletedNCT00811629
• Effects of Levosimendan on Microcirculation in Septic ShockCompletedNCT00800306Phase 2
• Terlipressin Administration in Septic Shock Refractory to CatecholaminesStatus unknownNCT00793559Phase 2
• Endothelium in Severe SepsisCompletedNCT00793442
• Norepinephrine Weaning in Septic PatientsCompletedNCT00763906Phase 4
• Angiotensin in Septic Kidney Injury TrialStatus unknownNCT00711789Phase 2
• Volume Replacement With Albumin in Severe SepsisCompletedNCT00707122Phase 3
• Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic ShockCompletedNCT00698048
• Tryptophan, Serotonin and Kynurenine in Septic ShockCompletedNCT00684736
• Phenylephrine in Septic ShockCompletedNCT00639015Phase 2
• Early Use of Polymyxin B Hemoperfusion in Abdominal SepsisCompletedNCT00629382Phase 4
• Terlipressin in Septic Shock in CirrhosisCompletedNCT00628160Phase 2/3
• Activated Protein C and Corticosteroids for Human Septic ShockCompletedNCT00625209Phase 3
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• External Cooling in Septic Shock PatientsCompletedNCT00527007Not applicable
• IL 6 Measurement Using a New Densitometric Bedside (POC) TestCompletedNCT00525369
• Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic ShockCompletedNCT00523198
• The Effect of Nitroglycerine on Microcirculatory Abnormalities During SepsisCompletedNCT00493415Phase 3
• Continuous Infusion of Terlipressin in Septic ShockCompletedNCT00481572Phase 2
• Phenylephrine Versus Norepinephrine in Septic ShockCompletedNCT00481442Phase 2
• Simvastatin in Patients With Septic ShockStatus unknownNCT00450840Phase 4
• Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation MonitoringCompletedNCT00407823Not applicable
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe SepsisCompletedNCT00406198Phase 4
• A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.CompletedNCT00398736
• Skeletal Muscle Oxygenation in Critically IllStatus unknownNCT00384644
• Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic ShockStatus unknownNCT00378586
• Protocol-driven Hemodynamic Support for Patients With Septic ShockStatus unknownNCT00335907Not applicable
• COMPACT - COMbining Plasma-filtration and Adsorption Clinical TrialTerminatedNCT00332371Not applicable
• The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of SepsisCompletedNCT00329680Phase 4
• Early Albumin Resuscitation During Septic ShockCompletedNCT00327704Phase 4
• Combination of Corticotherapy and Intensive Insulin Therapy for Septic ShockCompletedNCT00320099Phase 3
• Comparison of Vasopressin and Other Pressors in Septic ShockCompletedNCT00269685Phase 2/3
• Observational Study of Sepsis and Pneumonia to Develop Diagnostic TestsStatus unknownNCT00258869
• Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)CompletedNCT00241228Not applicable
• Selenium, as Sodium Selenite, in the Treatment of Septic ShockCompletedNCT00207844Phase 2
• Lactic Acid in the Rectum and Life-Threatening InfectionCompletedNCT00197938
• Dose of Norepinephrine and the Concentration of L-Lactate in the Rectum and Stomach in Patients With Septic Shock.CompletedNCT00197886Not applicable
• Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic ShockCompletedNCT00159952Phase 2/3
• Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic ShockCompletedNCT00148278Phase 2/3
• Corticosteroid Therapy of Septic Shock - CorticusCompletedNCT00147004Phase 3
• Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)CompletedNCT00135473Phase 3
• Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic ShockCompletedNCT00134212Phase 2
• Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in ChildrenCompletedNCT00118664
• A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe SepsisCompletedNCT00046072Phase 2
• Diagnostic Study of Adrenal Cortical Function in Children With Septic ShockCompletedNCT00005890Not applicable
• Ibuprofen in Sepsis StudyCompletedNCT00000574Phase 3

← Shock, Septic overview